TrialCellular & molecular immunology2012

Anti-γδ TCR antibody-expanded γδ T cells: a better choice for the adoptive immunotherapy of lymphoid malignancies.

Jianhua Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.